Texas Tech University System
Company
Texas Tech University System develops one asset, in phase 1 (DeltaGold in obesity). Mostly supplement acting on Oxidative stress and ROS signalling and inflammation.
- 1
- Asset
- Furthest stage
- Phase 1
- 1
- Grant
- 18
- Trials
- 0
- Signals
Pipeline
1Vitamin E tocotrienol antioxidant mitigating obesity-induced chronic inflammation.
Phase 1, Supplement, Oxidative stress and ROS signalling, Inflammation, obesity, postmenopausal women
Full company profiles: pipeline, trials, funding and people.
Subsidiaries
1Texas Tech University Health Sciences Center
1 asset, 18 trials
In the full profile
- Evidence behind the mechanisms2
- Trials19
- Signals1
- Similar companies6